# Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

> **NCT01181726** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Estradiol/Norethindrone acetate
- **DRUG:** Activella®

## Key facts

- **NCT ID:** NCT01181726
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181726, "Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01181726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*